EN / 中文
Lift to Zenith with
Novel Immunotherapies


Transforming lives through novel immunotherapies

We are an immunotherapy-focused biotech company pursuing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. As a global facing company, we are dedicated to developing immunotherapies capable of overcoming resistance and boosting anti-tumor immunity based on reverse translational science and emerging biology of tumor microenvironment -- breaking new ground in the biotech industry in both China and worldwide.